The US FDA notified the public that the use of stomach acid drugs known as proton pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea (CDAD). A diagnosis of CDAD should be considered for patients taking PPIs who develop diarrhea that does not improve. The FDA is working with manufacturers […]

Continue reading about Drug Safety Communication: Clostridium Difficile-Associated Diarrhea (CDAD) Associated With Stomach Acid Drugs